Literature DB >> 30665815

Development and Prospective Randomized Evaluation of a Decision Aid for Prostate-specific Antigen-based Early Detection of Prostate Cancer in Men Aged Between 55 and 69Yr: The PSAInForm Trial.

Axel Semjonow1, Hans-Werner Hense2, Kathrin Schlößler3, Alexandra Simbrich2, Matthias Borowski4, Christiane Bothe5, Klaus Kruse5, Dorothee Tiedje5, Kathrin Kuss3, Charles Christian Adarkwah6, Peter Maisel7, Ralf Jendyk7, Marc-André Kurosinski2, Joachim Gerß4, Oliver Heidinger8, Christian Tschuschke9, Ralf Becker10, Monique J Roobol11, Chris Bangma11, Norbert Donner-Banzhoff3.   

Abstract

For men interested in early detection of prostate cancer, the potential impact on decisional conflict of a decision aid with or without cost compensation for the prostate-specific antigen test will be investigated.
Copyright © 2019 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Year:  2019        PMID： 30665815     DOI： 10.1016/j.eururo.2019.01.008

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


  1 in total

1.  Decision aid and cost compensation influence uptake of PSA-based early detection without affecting decisional conflict: a cluster randomised trial.

Authors:  Dorothee Tiedje; Matthias Borowski; Alexandra Simbrich; Kathrin Schlößler; Klaus Kruse; Christiane Bothe; Katrin Kuss; Charles Christian Adarkwah; Peter Maisel; Ralf Jendyk; Marc-André Kurosinski; Joachim Gerß; Christian Tschuschke; Ralf Becker; Monique J Roobol; Chris H Bangma; Hans-Werner Hense; Norbert Donner-Banzhoff; Axel Semjonow
Journal:  Sci Rep       Date:  2021-12-06       Impact factor: 4.379
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.